# Rexford Industrial Realty, Inc.: financial statements, quarterly

REXR · NYSE · CIK 1571283 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rexr.md) · [Financials](/companies/rexr/financials.md) · [Filings](/companies/rexr/filings.md) · [Insiders](/companies/rexr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rexr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.2 d](/filings/0001571283-26-000006.md) | [0.1](/filings/0001571283-25-000025.md) | [0.2](/filings/0001571283-25-000038.md) | [0.2](/filings/0001571283-25-000054.md) | [0.2 d](/filings/0001571283-26-000006.md) | [0.1](/filings/0001571283-26-000020.md) | [0.1](/filings/0001571283-26-000040.md) | [0.1](/filings/0001571283-26-000064.md) | [0.2 d](/filings/0001571283-26-000006.md) | [0.0](/filings/0001571283-26-000020.md) | [0.0](/filings/0001571283-26-000040.md) | [0.0](/filings/0001571283-26-000064.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [14.6 d](/filings/0001571283-25-000006.md) | [14.7](/filings/0001571283-25-000025.md) | [28.4](/filings/0001571283-25-000038.md) | [27.3](/filings/0001571283-25-000054.md) | [28.2 d](/filings/0001571283-25-000006.md) | [27.3](/filings/0001571283-25-000025.md) | [26.7](/filings/0001571283-25-000038.md) | [25.5](/filings/0001571283-25-000054.md) | [25.5 d](/filings/0001571283-26-000006.md) | [26.6](/filings/0001571283-26-000020.md) | [28.6](/filings/0001571283-26-000040.md) | [24.8](/filings/0001571283-26-000064.md) |
| Income tax | $m | not reported | [0.0](/filings/0001571283-25-000025.md) | [0.0](/filings/0001571283-25-000038.md) | [0.0](/filings/0001571283-25-000054.md) | not reported | [0.0](/filings/0001571283-26-000020.md) | [0.0](/filings/0001571283-26-000040.md) | [0.0](/filings/0001571283-26-000064.md) | not reported | [0.0](/filings/0001571283-26-000020.md) | [0.0](/filings/0001571283-26-000040.md) | [0.0](/filings/0001571283-26-000064.md) |
| Net income | $m | [64.4 d](/filings/0001571283-26-000006.md) | [61.4](/filings/0001571283-25-000025.md) | [82.5](/filings/0001571283-25-000038.md) | [67.8](/filings/0001571283-25-000054.md) | [62.2 d](/filings/0001571283-26-000006.md) | [71.2](/filings/0001571283-26-000020.md) | [116](/filings/0001571283-26-000040.md) | [89.9](/filings/0001571283-26-000064.md) | [(65.4) d](/filings/0001571283-26-000006.md) | [91.2](/filings/0001571283-26-000020.md) | [(504)](/filings/0001571283-26-000040.md) | [17.4](/filings/0001571283-26-000064.md) |
| Diluted EPS | $ per share | not reported | [0.27](/filings/0001571283-25-000025.md) | [0.37](/filings/0001571283-25-000038.md) | [0.30](/filings/0001571283-25-000054.md) | not reported | [0.30](/filings/0001571283-26-000020.md) | [0.48](/filings/0001571283-26-000040.md) | [0.37](/filings/0001571283-26-000064.md) | not reported | [0.38](/filings/0001571283-26-000020.md) | [(2.26)](/filings/0001571283-26-000040.md) | [0.07](/filings/0001571283-26-000064.md) |
| Basic EPS | $ per share | not reported | [0.27](/filings/0001571283-25-000025.md) | [0.37](/filings/0001571283-25-000038.md) | [0.30](/filings/0001571283-25-000054.md) | not reported | [0.30](/filings/0001571283-26-000020.md) | [0.48](/filings/0001571283-26-000040.md) | [0.37](/filings/0001571283-26-000064.md) | not reported | [0.38](/filings/0001571283-26-000020.md) | [(2.26)](/filings/0001571283-26-000040.md) | [0.07](/filings/0001571283-26-000064.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001571283-25-000054.md) | [0.3](/filings/0001571283-25-000025.md) | [0.1](/filings/0001571283-25-000038.md) | [0.1](/filings/0001571283-25-000054.md) | [0.1](/filings/0001571283-26-000064.md) | [0.5](/filings/0001571283-26-000020.md) | [0.4](/filings/0001571283-26-000040.md) | [0.2](/filings/0001571283-26-000064.md) | [0.2](/filings/0001571283-26-000064.md) | [0.1](/filings/0001571283-26-000020.md) | [0.0](/filings/0001571283-26-000040.md) | [0.4](/filings/0001571283-26-000064.md) |
| Total assets | $bn | [10.9](/filings/0001571283-25-000006.md) | [12.4](/filings/0001571283-24-000022.md) | [12.4](/filings/0001571283-24-000034.md) | [12.4](/filings/0001571283-24-000056.md) | [12.6](/filings/0001571283-26-000006.md) | [13.1](/filings/0001571283-25-000025.md) | [13.1](/filings/0001571283-25-000038.md) | [12.9](/filings/0001571283-25-000054.md) | [12.6](/filings/0001571283-26-000064.md) | [12.4](/filings/0001571283-26-000020.md) | [11.6](/filings/0001571283-26-000040.md) | [10.8](/filings/0001571283-26-000064.md) |
| Total liabilities | $bn | [2.8](/filings/0001571283-25-000006.md) | [4.0](/filings/0001571283-24-000022.md) | [4.0](/filings/0001571283-24-000034.md) | [4.0](/filings/0001571283-24-000056.md) | [3.9](/filings/0001571283-26-000006.md) | [3.9](/filings/0001571283-25-000025.md) | [3.9](/filings/0001571283-25-000038.md) | [3.8](/filings/0001571283-25-000054.md) | [3.8](/filings/0001571283-26-000064.md) | [3.8](/filings/0001571283-26-000020.md) | [3.7](/filings/0001571283-26-000040.md) | [3.3](/filings/0001571283-26-000064.md) |
| Long-term debt | $bn | [2.2](/filings/0001571283-25-000006.md) | [3.3](/filings/0001571283-24-000022.md) | [3.3](/filings/0001571283-24-000034.md) | [3.4](/filings/0001571283-24-000056.md) | [3.3](/filings/0001571283-26-000006.md) | [3.3](/filings/0001571283-25-000025.md) | [3.3](/filings/0001571283-25-000038.md) | [3.2](/filings/0001571283-25-000054.md) | [3.3](/filings/0001571283-26-000064.md) | [3.2](/filings/0001571283-26-000020.md) | [3.3](/filings/0001571283-26-000040.md) | [2.8](/filings/0001571283-26-000064.md) |
| Shareholders' equity | $bn | [7.8](/filings/0001571283-25-000006.md) | [8.0](/filings/0001571283-24-000022.md) | [8.0](/filings/0001571283-24-000034.md) | [8.1](/filings/0001571283-24-000056.md) | [8.3](/filings/0001571283-26-000006.md) | [8.8](/filings/0001571283-25-000025.md) | [8.8](/filings/0001571283-25-000038.md) | [8.7](/filings/0001571283-25-000054.md) | [8.5](/filings/0001571283-26-000064.md) | [8.3](/filings/0001571283-26-000020.md) | [7.5](/filings/0001571283-26-000040.md) | [7.2](/filings/0001571283-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [116 d](/filings/0001571283-26-000006.md) | [134](/filings/0001571283-25-000025.md) | [102 d](/filings/0001571283-25-000038.md) | [127 d](/filings/0001571283-25-000054.md) | [116 d](/filings/0001571283-26-000006.md) | [153](/filings/0001571283-26-000020.md) | [128 d](/filings/0001571283-26-000040.md) | [150 d](/filings/0001571283-26-000064.md) | [112 d](/filings/0001571283-26-000006.md) | [141](/filings/0001571283-26-000020.md) | [107 d](/filings/0001571283-26-000040.md) | [152 d](/filings/0001571283-26-000064.md) |
| Dividends paid | $m | [78.5 d](/filings/0001571283-26-000006.md) | [80.7](/filings/0001571283-25-000025.md) | [90.9 d](/filings/0001571283-25-000038.md) | [90.9 d](/filings/0001571283-25-000054.md) | [91.6 d](/filings/0001571283-26-000006.md) | [94.1](/filings/0001571283-26-000020.md) | [102 d](/filings/0001571283-26-000040.md) | [102 d](/filings/0001571283-26-000064.md) | [100 d](/filings/0001571283-26-000006.md) | [99.6](/filings/0001571283-26-000020.md) | [98.4 d](/filings/0001571283-26-000040.md) | [97.0 d](/filings/0001571283-26-000064.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001571283-26-000006.md) | [0.0](/filings/0001571283-26-000020.md) | [0.0 d](/filings/0001571283-26-000040.md) | [150 d](/filings/0001571283-26-000064.md) | [100 d](/filings/0001571283-26-000006.md) | [200](/filings/0001571283-26-000020.md) | [100 d](/filings/0001571283-26-000040.md) | [309 d](/filings/0001571283-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [196](/filings/0001571283-24-000022.md) | [201](/filings/0001571283-24-000034.md) | [205](/filings/0001571283-24-000056.md) | [214](/filings/0001571283-25-000025.md) | [217](/filings/0001571283-25-000038.md) | [219](/filings/0001571283-25-000054.md) | [227](/filings/0001571283-26-000020.md) | [236](/filings/0001571283-26-000040.md) | [235](/filings/0001571283-26-000064.md) | [228](/filings/0001571283-26-000020.md) | [224](/filings/0001571283-26-000040.md) | [221](/filings/0001571283-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 212,136,272 at 2026-10-21, from the cover of the [10-Q filed 2026-10-27](/filings/0001571283-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 16:41 ET. No prices; not investment advice.